ORBIMED ADVISORS LLC purchased 98.7% of their position (597.73K shares) of TRAWS PHARMA, INC. on the open market
Open‑market purchase worth $998.2K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 4/29/2026ACC: 0000947871-26-000481
+3.59M
Net shares
Net buyer
$998.2K
Total acquired
1
Open market trades
1B · 0S
4
Total transactions
3.59M acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+597.73K
Price / share
$1.67
Trade value
$998.21K
% of position
98.7%
4/16/2026
605.52K→1.20M
Total
Net shares
+597.73K
Net value
$998.21K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 4/16/2026 | P · Purchase | +597.73K | $1.67 | $998.21K | 98.7% | 605.52K | 1.20M |
| Total | +597.73K | $998.21K | ||||||
Derivative Transactions3
Series A Warrants (right to buy)
Indirect
Converts to
Common Stock
597.73K shares
Shares
+597.73K
Strike price
1.673
Held after
597.73K
Exercisable
—
4/16/2026
Series B Warrants (right to buy)
Indirect
Converts to
Common Stock
597.73K shares
Shares
+597.73K
Strike price
1.673
Held after
597.73K
Exercisable
—
4/16/2026
Series C Warrants (right to buy)
Indirect
Converts to
Common Stock
1.79M shares
Shares
+1.79M
Strike price
1.673
Held after
1.79M
Exercisable
—
4/16/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A Warrants (right to buy) Indirect | Common Stock597.73K shares | 4/16/2026 | P · Purchase | +597.73K | 1.673 | — | 597.73K |
| Series B Warrants (right to buy) Indirect | Common Stock597.73K shares | 4/16/2026 | P · Purchase | +597.73K | 1.673 | — | 597.73K |
| Series C Warrants (right to buy) Indirect | Common Stock1.79M shares | 4/16/2026 | P · Purchase | +1.79M | 1.673 | — | 1.79M |